Reply: To PMID 24691835

Affiliations

Comment

Salvatore Petta et al. Hepatology. 2015 Mar.

. 2015 Mar;61(3):1097.

doi: 10.1002/hep.27315. Epub 2015 Jan 20.

¹ Sezione di Gastroenterologia, Di.Bi.M.I.S, Università di Palermo, Palermo, Italy.

No abstract available

Comment on

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.
Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, Gasbarrini A, Craxì A, Cammà C; WEF Study Group. Petta S, et al. Hepatology. 2014 May;59(5):1692-705. doi: 10.1002/hep.27010. Epub 2014 Apr 1. Hepatology. 2014. PMID: 24691835
Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values.
Cortesi PA, Scalone L, Mantovani LG. Cortesi PA, et al. Hepatology. 2015 Mar;61(3):1096-7. doi: 10.1002/hep.27316. Epub 2015 Jan 20. Hepatology. 2015. PMID: 25043465 No abstract available.